Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices

Pediatrics

Volumn 104, Issue 3 I, 1999, Pages 501-506

  Bronsky, Edwin A ^a   Pearlman, David S ^b   Pobiner, Bonnie F ^c   Scott, Catherine ^c   Wang, Yonghua ^c   Stahl, Edmundo ^c  

^a Intermountain Clinical Research   (United States)

^b Respiratory Institute   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

2 agonists; Cardiovascular safety; Exercise induced bronchospasm; Pediatric; Powder drug delivery systems; Salmeterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALMETEROL;

ARTICLE; ASTHMA; BRONCHOSPASM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA, EXERCISE-INDUCED; BRONCHIAL SPASM; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; POWDERS; TIME FACTORS;

EID: 0032885137     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.3.501     Document Type: Article

References (25)

1. Silverman M, Anderson SD. Standardization of exercise tests in asthmatic children. Arch Dis Child. 1972;47:882-889
2. Kattan M, Keens TG, Mellis CM, Levison H. The response to exercise in normal and asthmatic children. J Pediatr. 1978;92:718-721
3. Silverman M, Konig P, Godfrey S. Use of serial exercise tests to assess the efficacy and duration of action of drugs for asthma. Thorax. 1973; 28:574-578
4. Nocon A. Social and emotional impact of childhood asthma. Arch Dis Child. 1991;66:458-460
5. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res. 1996;5:27-34
6. International Consensus Report on Diagnosis and Management of Asthma. Bethesda, MD: National Asthma Education Program; 1992. DHHS Publication No 92-3091
7. Boner AL, Spezia E, Piovesan P, Chiocca E, Maiocchi G. Inhaled formoterol in the prevention of exercise-induced bronchoconstricrion in asthmatic children. Am J Respir Crit Care Med. 1994;149:935-939
8. Anderson SD, Rodwell LT, Du Toit J, Young IH. Duration of protection by inhaled salmeterol in exercise-induced asthma. Chest. 1991;100: 1254-1260
9. The Ozone Secretariat. United Nations Environment Programme. The 1987 Montreal Protocol on Substances that Deplete the Ozone Layer. Montreal, Canada: United Nations Environment Programme; 1997
10. Carlsen KH, Roksund O, Olsholt K, Nja F, Leegaard J, Bratten G. Overnight protection by inhaled salmeterol on exercise-induced asthma in children. Eur Respir J. 1995;8:1852-1855
11. Ruggins NR, Milner AD. The prolonged effect of salmeterol hydroxynaphthoate on exercise induced bronchoconstriction in asthmatic children. Am Rev Respir Dis. 1991;143:A22
12. Green CP, Price JF. Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child. 1992;67:1014-1017
13. Eggleston PA, Rosenthal RR, Anderson SA, et al. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy. Guidelines for the methodology of exercise challenge testing of asthmatics. J Allergy Clin Immunol. 1971;64:642-645
14. Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Philadelphia, PA: WB Saunders; 1971
15. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225-244
16. Lemanske RF, Joad J. β-2 receptor agonists in asthma: a comparison. J Asthma. 1990;27:101-109
17. Landis R, Heyman E, Koch G. Average partial association in three-way contingency tables: a review and discussion of alternative tests. Int Stat Rev. 1978;46:237-254
18. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947;12: 153-157
19. Simons FER. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. N Engl J Med. 1997;337:1659-1665
20. Ramage L, Lipworth BJ, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med. 1994;88:363-368
21. Simons FE, Gerstner TV, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics. 1997;99:655-559
22. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med. 1998;339:141-146
23. Nielsen KG, Auk IL, Bojsen K, Ifversen M, Klug B, Bisgaard H. Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children. Eur Respir J. 1998;11:350-354
24. Fuller R. The Diskus: a new multi-dose powder device - efficacy and comparison with Turbuhaler. J Aerosol Med. 1995;8:11-17. Supplement 2
25. Boulet LP, Cowie R, Johnston P, Krakovsky D, Mark S, on behalf of a Canadian Study Group. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. J Asthma. 1995;32:429-436